11月26日,药明康德发布关于股东权益变动触及1%刻度的提示性公告。公告显示,11月20日至11月25日期间,信息披露义务人通过集中竞价方式合计减持公司股份1182.79万股,占公司总股本的0.40%。此次权益变动后,信息披露义务人及与实际控制人签署投票委托书的股东合计持股比例从18.46%减少至17.95%,权益变动触及1%刻度。此次减持实际为前期已披露计划的逐步实施。10月29日,药明康德...
Source Link11月26日,药明康德发布关于股东权益变动触及1%刻度的提示性公告。公告显示,11月20日至11月25日期间,信息披露义务人通过集中竞价方式合计减持公司股份1182.79万股,占公司总股本的0.40%。此次权益变动后,信息披露义务人及与实际控制人签署投票委托书的股东合计持股比例从18.46%减少至17.95%,权益变动触及1%刻度。此次减持实际为前期已披露计划的逐步实施。10月29日,药明康德...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.